PTCT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $13,398,165.88

PTC Therapeutics Insider Trading History Chart

PTC Therapeutics Share Price & Price History

^$47.39

▲ +0.98 (2.11%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

PTC Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/2/2025	Lee Scott Golden	EVP	Sell	897	$46.95	$42,114.15	75,997
3/13/2025	Stephanie S. Okey	Director	Sell	5,000	$54.00	$270,000.00	8,867
3/12/2025	Mark Elliott Boulding	VP	Sell	15,521	$53.30	$827,269.30	103,901
3/4/2025	Allan Steven Jacobson	Director	Sell	1,230	$51.52	$63,369.60	19,118
2/19/2025	Christine Marie Utter	CAO	Sell	879	$50.10	$44,037.90	63,442
2/19/2025	Eric Pauwels	CEO	Sell	1,378	$50.10	$69,037.80	85,427
2/19/2025	Lee Scott Golden	EVP	Sell	795	$50.10	$39,829.50	77,856
2/19/2025	Mark Elliott Boulding	VP	Sell	1,333	$50.10	$66,783.30	105,515
2/19/2025	Neil Gregory Almstead	Insider	Sell	1,300	$50.10	$65,130.00	101,931
2/19/2025	Pierre Gravier	CFO	Sell	1,168	$50.10	$58,516.80	75,603
1/7/2025	Christine Marie Utter	CAO	Sell	1,291	$45.34	$58,533.94	65,983
1/7/2025	Eric Pauwels	CEO	Sell	1,599	$45.34	$72,498.66	88,941
1/7/2025	Lee Scott Golden	EVP	Sell	810	$45.34	$36,725.40	79,849
1/7/2025	Mark Elliott Boulding	VP	Sell	1,543	$45.34	$69,959.62	108,846
1/7/2025	Neil Gregory Almstead	Insider	Sell	1,265	$45.34	$57,355.10	104,783
12/31/2024	Matthew B. Klein	CEO	Sell	8,279	$45.16	$373,879.64	217,528
12/2/2024	Christine Marie Utter	CAO	Sell	17,800	$51.77	$921,506.00	52,428
12/2/2024	Jerome B. Zeldis	Director	Sell	24,000	$51.50	$1,236,000.00	14,500
12/2/2024	Mark Elliott Boulding	VP	Sell	85,600	$52.26	$4,473,456.00	92,389
12/2/2024	Neil Gregory Almstead	Insider	Sell	69,550	$52.06	$3,620,773.00	86,202
7/16/2024	Pierre Gravier	CFO	Sell	2,269	$34.02	$77,191.38	53,531
5/22/2024	Jerome B. Zeldis	Director	Sell	20,000	$38.24	$764,800.00	14,500
5/7/2024	Lee Scott Golden	EVP	Sell	175	$32.82	$5,743.50	59,813
4/19/2024	Matthew B. Klein	CEO	Sell	3,361	$24.89	$83,655.29	225,807
4/17/2024	Eric Pauwels	CEO	Sell	787	$25.14	$19,785.18	67,694
4/2/2024	Lee Scott Golden	EVP	Sell	526	$28.37	$14,922.62	59,988
1/30/2024	Christine Marie Utter	CAO	Sell	318	$27.25	$8,665.50	35,528
1/30/2024	Mark Elliott Boulding	VP	Sell	794	$27.25	$21,636.50	71,189
1/30/2024	Neil Gregory Almstead	Insider	Sell	618	$27.25	$16,840.50	61,202
1/22/2024	Allan Steven Jacobson	Director	Sell	10,000	$27.38	$273,800.00	12,348
1/8/2024	Christine Marie Utter	CAO	Sell	1,188	$28.64	$34,024.32	37,499
1/8/2024	Eric Pauwels	Insider	Sell	1,569	$28.64	$44,936.16	46,612
1/8/2024	Mark Elliott Boulding	VP	Sell	1,457	$28.64	$41,728.48	73,921
1/8/2024	Matthew B. Klein	CEO	Sell	2,237	$28.64	$64,067.68	165,918
1/8/2024	Michael Schmertzler	Director	Sell	1,500	$27.81	$41,715.00	115,266
1/5/2024	Matthew B. Klein	CEO	Sell	10,107	$27.15	$274,405.05	168,155
12/12/2023	Pierre Gravier	CFO	Buy	7,700	$25.81	$198,737.00	33,700
9/6/2023	Alethia Young	Director	Sell	11,666	$39.86	$465,006.76	9,067
5/11/2023	Allan Steven Jacobson	Director	Sell	23,000	$55.08	$1,266,840.00	12,348
4/21/2023	Christine Marie Utter	CAO	Sell	4,692	$55.06	$258,341.52	38,059
4/21/2023	Emma Reeve	Director	Sell	4,328	$55.05	$238,256.40	7,200
4/18/2023	Eric Pauwels	Insider	Sell	732	$52.04	$38,093.28	64,805
4/18/2023	Matthew B. Klein	CEO	Sell	1,211	$52.04	$63,020.44	102,645
4/17/2023	David P. Southwell	Director	Sell	11,429	$51.03	$583,221.87	10,500
4/17/2023	Mark Elliott Boulding	VP	Sell	61,923	$51.42	$3,184,080.66	75,378
3/31/2023	David P. Southwell	Director	Sell	2,571	$50.05	$128,678.55	10,500
3/29/2023	Christine Marie Utter	CAO	Sell	4,688	$47.79	$224,039.52	38,059
3/27/2023	Christine Marie Utter	CAO	Sell	26,658	$45.09	$1,202,009.22	38,059
3/27/2023	David P. Southwell	Director	Sell	10,000	$45.10	$451,000.00	10,500
3/27/2023	Emily Luisa Hill	CFO	Sell	7,363	$45.00	$331,335.00	38,925
1/31/2023	Christine Marie Utter	CAO	Sell	325	$45.63	$14,829.75	38,059
1/31/2023	Emily Luisa Hill	CFO	Sell	575	$45.63	$26,237.25	46,288
1/31/2023	Eric Pauwels	Insider	Sell	375	$45.63	$17,111.25	65,537
1/31/2023	Mark Elliott Boulding	VP	Sell	812	$45.63	$37,051.56	75,378
1/31/2023	Stuart Walter Peltz	CEO	Sell	2,320	$45.63	$105,861.60	166,962
1/24/2023	Emily Luisa Hill	CFO	Sell	223	$47.45	$10,581.35	46,863
1/24/2023	Eric Pauwels	Insider	Sell	359	$47.45	$17,034.55	65,912
1/24/2023	Stuart Walter Peltz	CEO	Sell	284	$47.45	$13,475.80	55,204
1/11/2023	Christine Marie Utter	CAO	Sell	417	$44.36	$18,498.12	38,384
1/11/2023	Emily Luisa Hill	CFO	Sell	418	$44.36	$18,542.48	47,086
1/11/2023	Mark Elliott Boulding	VP	Sell	495	$44.36	$21,958.20	76,190
1/11/2023	Matthew B. Klein	COO	Sell	2,244	$44.36	$99,543.84	77,856
1/11/2023	Neil Gregory Almstead	Insider	Sell	383	$44.36	$16,989.88	64,579
1/11/2023	Stuart Walter Peltz	CEO	Sell	1,189	$44.36	$52,744.04	169,282
1/9/2023	Christine Marie Utter	CAO	Sell	706	$41.66	$29,411.96	39,290
1/9/2023	Emily Luisa Hill	CFO	Sell	758	$41.66	$31,578.28	48,001
1/9/2023	Mark Elliott Boulding	VP	Sell	835	$41.66	$34,786.10	77,275
1/9/2023	Matthew B. Klein	COO	Sell	731	$41.66	$30,453.46	82,373
1/9/2023	Neil Gregory Almstead	Insider	Sell	716	$41.66	$29,828.56	65,435
1/9/2023	Stuart Walter Peltz	CEO	Sell	1,786	$41.66	$74,404.76	171,699
10/18/2022	Mark Elliott Boulding	VP	Sell	299	$55.06	$16,462.94	61,110
9/20/2022	Mark Elliott Boulding	VP	Sell	1,176	$55.00	$64,680.00	61,110
8/9/2022	Stephanie S. Okey	Director	Sell	2,296	$51.62	$118,519.52	1,867
6/7/2022	Stuart Walter Peltz	CEO	Sell	407	$26.83	$10,919.81	38,239
4/19/2022	Eric Pauwels	Insider	Sell	822	$42.52	$34,951.44	49,772
4/19/2022	Matthew B. Klein	COO	Sell	897	$42.52	$38,140.44	56,564

See Full Table

SEC Filings (Institutional Ownership Changes) for PTC Therapeutics (NASDAQ:PTCT)

Institutional Buying and Selling by Quarter

PTC Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/16/2025	Wealth Enhancement Advisory Services LLC	11,670	$0.60M	0.0%	N/A	0.015%
4/15/2025	Assenagon Asset Management S.A.	337,960	$17.22M	0.0%	-23.1%	0.429%
4/15/2025	GAMMA Investing LLC	952	$49K	0.0%	+86.3%	0.001%
4/14/2025	Harbor Capital Advisors Inc.	40,725	$2.08M	0.1%	-22.6%	0.052%
4/14/2025	Pallas Capital Advisors LLC	6,925	$0.35M	0.0%	N/A	0.009%
4/9/2025	Merit Financial Group LLC	4,028	$0.21M	0.0%	N/A	0.005%
4/8/2025	Rhumbline Advisers	111,813	$5.70M	0.0%	-0.5%	0.142%
4/7/2025	GAMMA Investing LLC	48,514	$2.47M	0.0%	+9,393.9%	0.062%
3/18/2025	California State Teachers Retirement System	65,254	$2.95M	0.0%	-0.9%	0.083%
2/28/2025	Universal Beteiligungs und Servicegesellschaft mbH	108,345	$4.89M	0.0%	N/A	0.140%
2/20/2025	Mackenzie Financial Corp	22,776	$1.03M	0.0%	+132.2%	0.030%
2/19/2025	Toronto Dominion Bank	3,286,729	$148.36M	0.2%	N/A	4.262%
2/19/2025	GF Fund Management CO. LTD.	1,619	$73K	0.0%	N/A	0.002%
2/19/2025	Public Employees Retirement System of Ohio	5,542	$0.25M	0.0%	-76.1%	0.007%
2/18/2025	Vise Technologies Inc.	10,215	$0.46M	0.0%	-6.2%	0.013%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	160,251	$7.23M	0.0%	+19.6%	0.208%
2/17/2025	Voloridge Investment Management LLC	568,364	$25.66M	0.1%	-14.0%	0.737%
2/17/2025	Woodline Partners LP	155,883	$7.04M	0.0%	N/A	0.202%
2/17/2025	Two Sigma Advisers LP	360,442	$16.27M	0.0%	-16.1%	0.467%
2/17/2025	Two Sigma Investments LP	173,352	$7.83M	0.0%	-45.4%	0.225%
2/17/2025	State of Wyoming	5,776	$0.26M	0.0%	N/A	0.007%
2/17/2025	Toronto Dominion Bank	3,286,729	$148.36M	0.2%	N/A	4.262%
2/17/2025	Rafferty Asset Management LLC	78,032	$3.52M	0.0%	-22.9%	0.101%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	1,706	$77K	0.0%	N/A	0.002%
2/17/2025	Point72 Asset Management L.P.	1,443,362	$65.15M	0.1%	+150.6%	1.872%
2/17/2025	Point72 Hong Kong Ltd	32,436	$1.46M	0.1%	+184.5%	0.042%
2/17/2025	ProShare Advisors LLC	25,102	$1.13M	0.0%	+32.5%	0.033%
2/17/2025	Quantinno Capital Management LP	9,656	$0.44M	0.0%	N/A	0.013%
2/17/2025	MPM Bioimpact LLC	434,767	$19.63M	2.8%	+384.6%	0.564%
2/17/2025	Parkman Healthcare Partners LLC	177,368	$8.01M	1.1%	-9.0%	0.230%
2/17/2025	Nuveen Asset Management LLC	1,077,794	$48.65M	0.0%	+34.0%	1.398%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	46,894	$2.12M	0.2%	+49.2%	0.061%
2/17/2025	Millennium Management LLC	309,423	$13.97M	0.0%	+41.0%	0.401%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	65,681	$2.97M	0.0%	+0.3%	0.085%
2/17/2025	Lazard Asset Management LLC	45,647	$2.06M	0.0%	+294.3%	0.059%
2/17/2025	Jacobs Levy Equity Management Inc.	826,519	$37.31M	0.1%	-44.4%	1.072%
2/17/2025	Janus Henderson Group PLC	2,325,915	$105.02M	0.1%	+24.4%	3.016%
2/17/2025	Graham Capital Management L.P.	14,998	$0.68M	0.0%	N/A	0.019%
2/17/2025	Deutsche Bank AG	94,378	$4.26M	0.0%	+92.3%	0.122%
2/17/2025	Driehaus Capital Management LLC	1,041,059	$46.99M	0.4%	N/A	1.350%
2/17/2025	Cubist Systematic Strategies LLC	141,410	$6.38M	0.0%	+133.1%	0.183%
2/17/2025	Blackstone Inc.	1,059,574	$47.83M	0.2%	-3.3%	1.374%
2/17/2025	Brevan Howard Capital Management LP	12,197	$0.55M	0.0%	N/A	0.016%
2/17/2025	Baker BROS. Advisors LP	20,400	$0.92M	0.0%	N/A	0.026%
2/17/2025	Bellevue Group AG	3,800	$0.17M	0.0%	N/A	0.005%
2/17/2025	Bank of America Corp DE	256,536	$11.58M	0.0%	-18.5%	0.333%
2/17/2025	BNP Paribas Financial Markets	10,292	$0.47M	0.0%	-85.9%	0.013%
2/17/2025	Ameriprise Financial Inc.	42,934	$1.94M	0.0%	-37.8%	0.056%
2/14/2025	PDT Partners LLC	92,081	$4.16M	0.4%	-44.2%	0.119%
2/14/2025	Schonfeld Strategic Advisors LLC	122,280	$5.52M	0.0%	-35.4%	0.159%
2/14/2025	AQR Capital Management LLC	157,349	$7.10M	0.0%	-17.0%	0.204%
2/14/2025	Northern Trust Corp	727,976	$32.86M	0.0%	+7.8%	0.944%
2/14/2025	The Manufacturers Life Insurance Company	41,574	$1.88M	0.0%	-3.3%	0.054%
2/14/2025	Tudor Investment Corp ET AL	47,151	$2.13M	0.0%	+22.0%	0.061%
2/14/2025	Aquatic Capital Management LLC	69,869	$3.15M	0.1%	+578.3%	0.091%
2/14/2025	Susquehanna Fundamental Investments LLC	31,670	$1.43M	0.0%	N/A	0.041%
2/14/2025	Virtus ETF Advisers LLC	7,383	$0.33M	0.1%	-17.3%	0.010%
2/14/2025	Nebula Research & Development LLC	9,492	$0.43M	0.1%	N/A	0.012%
2/14/2025	Adage Capital Partners GP L.L.C.	306,756	$13.85M	0.0%	+22.7%	0.398%
2/14/2025	Price T Rowe Associates Inc. MD	509,204	$22.99M	0.0%	-9.0%	0.660%
2/14/2025	Dark Forest Capital Management LP	9,637	$0.44M	0.1%	+45.0%	0.012%
2/14/2025	Hsbc Holdings PLC	16,468	$0.75M	0.0%	-21.5%	0.021%
2/14/2025	Teachers Retirement System of The State of Kentucky	20,822	$0.94M	0.0%	N/A	0.027%
2/14/2025	Tower Research Capital LLC TRC	16,553	$0.75M	0.0%	+3,636.6%	0.021%
2/14/2025	MetLife Investment Management LLC	46,588	$2.10M	0.0%	+5.9%	0.060%
2/14/2025	Dimensional Fund Advisors LP	105,050	$4.74M	0.0%	N/A	0.136%
2/14/2025	First Trust Advisors LP	133,763	$6.04M	0.0%	+24.0%	0.173%
2/14/2025	Alpha DNA Investment Management LLC	10,258	$0.46M	0.2%	N/A	0.013%
2/13/2025	Canada Pension Plan Investment Board	23,500	$1.06M	0.0%	N/A	0.030%
2/13/2025	Jump Financial LLC	62,809	$2.84M	0.1%	N/A	0.081%
2/13/2025	Guggenheim Capital LLC	19,486	$0.88M	0.0%	-22.5%	0.025%
2/13/2025	Walleye Capital LLC	110,004	$4.97M	0.0%	N/A	0.143%
2/13/2025	XTX Topco Ltd	13,223	$0.60M	0.0%	N/A	0.017%
2/13/2025	Barclays PLC	163,848	$7.40M	0.0%	-1.9%	0.212%
2/13/2025	Summit Investment Advisors Inc.	7,968	$0.36M	0.3%	+3.3%	0.010%
2/13/2025	Rockefeller Capital Management L.P.	492,420	$22.23M	0.1%	-0.2%	0.639%
2/13/2025	Sterling Capital Management LLC	645	$29K	0.0%	+424.4%	0.001%
2/13/2025	Raymond James Financial Inc.	48,728	$2.20M	0.0%	N/A	0.063%
2/13/2025	Martingale Asset Management L P	15,038	$0.68M	0.0%	-8.8%	0.019%
2/13/2025	Renaissance Technologies LLC	653,100	$29.48M	0.0%	+21.3%	0.847%
2/13/2025	Legal & General Group Plc	80,628	$3.64M	0.0%	-5.8%	0.105%
2/13/2025	Invesco Ltd.	111,391	$5.03M	0.0%	+107.0%	0.144%
2/13/2025	ADAR1 Capital Management LLC	48,023	$2.17M	0.4%	+140.1%	0.062%
2/13/2025	Federated Hermes Inc.	47,828	$2.16M	0.0%	N/A	0.062%
2/13/2025	Russell Investments Group Ltd.	170,697	$7.71M	0.0%	-26.5%	0.221%
2/13/2025	Wells Fargo & Company MN	38,148	$1.72M	0.0%	+43.1%	0.049%
2/12/2025	Massachusetts Financial Services Co. MA	43,475	$1.96M	0.0%	-2.9%	0.056%
2/12/2025	Trexquant Investment LP	313,417	$14.15M	0.2%	+43.8%	0.406%
2/12/2025	Headlands Technologies LLC	7,228	$0.33M	0.0%	+843.6%	0.009%
2/12/2025	Geode Capital Management LLC	1,797,016	$81.14M	0.0%	-0.1%	2.330%
2/12/2025	Alliancebernstein L.P.	361,644	$16.33M	0.0%	+62.9%	0.469%
2/12/2025	Wellington Management Group LLP	4,787,123	$216.09M	0.0%	-39.3%	6.070%
2/12/2025	Pictet Asset Management Holding SA	736,388	$33.24M	0.0%	+107.4%	0.955%
2/11/2025	Prudential Financial Inc.	5,620	$0.25M	0.0%	-5.5%	0.007%
2/11/2025	Corebridge Financial Inc.	37,864	$1.71M	0.0%	-7.0%	0.049%
2/11/2025	Vanguard Group Inc.	9,178,822	$414.33M	0.0%	+0.6%	11.902%
2/11/2025	KLP Kapitalforvaltning AS	14,300	$0.65M	0.0%	N/A	0.019%
2/11/2025	Sei Investments Co.	5,274	$0.24M	0.0%	N/A	0.007%
2/11/2025	American Century Companies Inc.	60,150	$2.72M	0.0%	+66.8%	0.078%
2/11/2025	Sector Gamma AS	65,250	$2.95M	1.0%	N/A	0.085%

Data available starting January 2016

See Full Table

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and ferroptosis and inflammation platforms, including vatiquinone to treat Friedreich ataxia and utreloxastat for the treatment of amyotrophic lateral sclerosis. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd, Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

Today's Range

Now: $47.39

$45.95

$47.96

50 Day Range

MA: $50.20

$39.77

$57.17

52 Week Range

Now: $47.39

$24.00

$58.38

Volume

1,036,666 shs

Average Volume

821,659 shs

Market Capitalization

$3.74 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.58

Who are the company insiders with the largest holdings of PTC Therapeutics?: PTC Therapeutics' top insider shareholders include:
Matthew B Klein (CEO)
Michael Schmertzler (Director)
Mark Elliott Boulding (VP)
Neil Gregory Almstead (Insider)
Eric Pauwels (CEO)
Lee Scott Golden (EVP)
Pierre Gravier (CFO)
Christine Marie Utter (CAO)
Eric Pauwels (Insider)
Allan Steven Jacobson (Director)
Jerome B Zeldis (Director)
Alethia Young (Director)
Stephanie Okey (Director)
Emma Reeve (Director)
Learn More about top insider investors at PTC Therapeutics.
Who are the major institutional investors of PTC Therapeutics?: PTC Therapeutics' top institutional investors include:
Assenagon Asset Management S.A. — 0.43%
Rhumbline Advisers — 0.14%
GAMMA Investing LLC — 0.06%
Harbor Capital Advisors Inc. — 0.05%
Wealth Enhancement Advisory Services LLC — 0.01%
Pallas Capital Advisors LLC — 0.01%
Learn More about top institutional investors of PTC Therapeutics stock.
Which major investors are selling PTC Therapeutics stock?: During the previous quarter, PTCT stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Harbor Capital Advisors Inc.
Rhumbline Advisers
Within the previous year, company insiders that have sold PTC Therapeutics company stock include:
Matthew B Klein (CEO)
Michael Schmertzler (Director)
Mark Elliott Boulding (VP)
Neil Gregory Almstead (Insider)
Eric Pauwels (CEO)
Lee Scott Golden (EVP)
Pierre Gravier (CFO)
Christine Marie Utter (CAO)
Eric Pauwels (Insider)
Allan Steven Jacobson (Director)
Learn More investors selling PTC Therapeutics stock.
Which major investors are buying PTC Therapeutics stock?: Within the previous quarter, PTCT stock was bought by institutional investors including:
GAMMA Investing LLC
Wealth Enhancement Advisory Services LLC
Pallas Capital Advisors LLC
Merit Financial Group LLC
GAMMA Investing LLC